Physician profile
Daniela D Ferrell
NPI 1063061042
$765.24
in general payments reported to CMS, 2019-2025
13 companies · $253 in 2025
The $253 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $498 · 2022: $13.64 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $253.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $178.54 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $169.65 | 2021 | |
| Pfizer INC. | $91.81 | 2021-2022 | |
| Abbvie INC. | $74.94 | 2025 | |
| Amgen INC. | $55.39 | 2021 | |
| Novartis Pharmaceuticals Corporation | $44.39 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $40.35 | 2021 | |
| Arbor Pharmaceuticals, INC. | $31.56 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $19.45 | 2021 | |
| Medtronic, INC. | $16.65 | 2021 | |
| Amarin Pharma, INC. | $15.57 | 2021 | |
| Janssen Pharmaceuticals, INC | $13.47 | 2021 | |
| Merck Sharp & Dohme LLC | $13.47 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniela Ferrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.